Related Experiment Video
Updated: May 22, 2026

Neisseria meningitidis Infection of Induced Pluripotent Stem-Cell Derived Brain Endothelial Cells
Published on: July 14, 2020
Youngest survivor of naegleria meningitis
Dinesh Yadav1, Satinder Aneja, Renu Dutta
1Division of Pediatric Neurology, Department of Pediatrics, Lady Hardinge Medical College and associated Kalawati Saran Children's Hospital, New Delhi 110001, India.
Abstract:
Primary amebic meningoencephalitis (PAME) is a rare condition, usually caused by free living motile amebae. These are universally fatal infections with very few survivors reported till now. The authors report a 25-d-old boy, the youngest survivor of Naegleria meningitis. The child was admitted with a diagnosis of partially treated meningitis. Cerebro-spinal fluid wet mount examination revealed free living motile amebae resembling Naegleria, which was further confirmed by culture. He was treated with amphoterecin B, rifampicin and fluconazole for 4 wk and ventriculoperitoneal shunt for obstructive hydrocephalous. At 8 mo follow up, child has survived with neurological sequlae.
Insights
Primary amebic meningoencephalitis (PAME) is a rare, fatal infection. This case study details the youngest survivor of Naegleria meningitis, highlighting a novel treatment approach and long-term outcomes.
Area of Science:
- Neurology
- Infectious Diseases
- Microbiology
Background:
- Primary amebic meningoencephalitis (PAME) is a rare and almost universally fatal infection caused by free-living amebae.
- Naegleria species are the most common causative agents of PAME, leading to severe central nervous system inflammation.
- Survival rates for PAME are extremely low, with limited treatment options and significant neurological sequelae.
Observation:
- A 25-day-old infant presented with symptoms of partially treated meningitis.
- Cerebrospinal fluid analysis revealed motile amebae consistent with Naegleria, confirmed by culture.
- The infant required a ventriculoperitoneal shunt due to obstructive hydrocephalus.
Findings:
- The infant received a 4-week course of Amphotericin B, rifampicin, and fluconazole.
- This treatment regimen, combined with surgical intervention, resulted in survival.
- At 8 months follow-up, the child survived but exhibited neurological sequelae.
Implications:
- This case represents the youngest reported survivor of Naegleria meningitis.
- The successful treatment highlights potential therapeutic strategies for PAME.
- Further research into early diagnosis and effective treatments for PAME is warranted to improve patient outcomes.
Related Concept Videos
Viral Meningitis
Bacterial Meningitis II: Pathophysiology
Bacterial Meningitis I: Introduction
Arboviral Encephalitis
Encephalitis l: Introduction
